00:19 , Jun 24, 2016 |  BC Extra  |  Financial News

Annexon raises $44M in B round

Annexon Biosciences Inc. (South San Francisco, Calif.) raised $44 million in a series B round led by new investor New Enterprise Associates. New investor Correlation Ventures also participated, as did existing investors including Novartis Venture...
07:00 , Jun 15, 2015 |  BioCentury  |  Finance

Products, hold the platform

While many VCs are pumping record-breaking amounts of capital into big idea platform companies and urging them to fully explore their technologies, Clarus Ventures is sticking with its more measured approach. In addition to keeping...
08:00 , Dec 22, 2014 |  BioCentury  |  Finance

Annexon connections

Novartis Venture Fund...
03:17 , Dec 16, 2014 |  BC Extra  |  Financial News

Annexon raises $34M in series A-1

Annexon Bioscience raised $34 million in a series A-1 round led by Novartis Venture Fund along with Satter Investment Management and Clarus Ventures. All were new investors. CEO Doug Love told BioCentury the round is...